These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27294367)

  • 21. Quantitative evaluation of striatal I-123-FP-CIT uptake in essential tremor and parkinsonism.
    Cuberas-Borrós G; Lorenzo-Bosquet C; Aguadé-Bruix S; Hernández-Vara J; Pifarré-Montaner P; Miquel F; Álvarez-Sabin J; Castell-Conesa J
    Clin Nucl Med; 2011 Nov; 36(11):991-6. PubMed ID: 21975386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
    Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
    J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Striatal Dopamine, Cerebral Small Vessel Disease, and Other Risk Factors on Age-Related Parkinsonian Motor Signs.
    Rosano C; Metti AL; Rosso AL; Studenski S; Bohnen NI
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):696-701. PubMed ID: 31425570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential alterations of dopamine transporter in the striatum and midbrain in patients with parkinsonian syndrome.
    Matesan MC; Cross DJ; Lewis DH; Minoshima S
    Clin Nucl Med; 2015 Mar; 40(3):191-4. PubMed ID: 25546191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal parkinsonism in the elderly is associated with striatal dopamine loss and pontine structural damage.
    Chung SJ; Yoo HS; Lee YH; Sohn YH; Ye BS; Cha J; Lee PH
    Parkinsonism Relat Disord; 2020 Dec; 81():140-143. PubMed ID: 33130476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion.
    Oh SW; Shin NY; Yoon U; Sin I; Lee SK
    Sci Rep; 2020 Jul; 10(1):11617. PubMed ID: 32669608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of parkinsonism and striatal dopamine transporter loss in patients with spinocerebellar ataxia type 6.
    Xie T; Appelbaum D; Bernard J; Padmanaban M; Pu Y; Gomez C
    J Neurol; 2016 Nov; 263(11):2302-2307. PubMed ID: 27544504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Lee CS; Kim JS
    Nucl Med Mol Imaging; 2013 Mar; 47(1):44-51. PubMed ID: 24895507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phase value of putamen measured by susceptibility weighted images in Parkinson's disease and in other forms of Parkinsonism: a correlation study with F18 FP-CIT PET.
    Kwon GH; Jang J; Choi HS; Hwang EJ; Jung SL; Ahn KJ; Kim BS; Yoo IeR; Kim SH; Haacke EM
    Acta Radiol; 2016 Jul; 57(7):852-60. PubMed ID: 26377263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism.
    Honkanen EA; Kemppainen N; Noponen T; Seppänen M; Joutsa J; Kaasinen V
    Clin Neuropharmacol; 2019; 42(5):181-183. PubMed ID: 31361666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of [123I]FP-CIT binding to the dopamine transporter in the striatum of tree shrews by quantitative in vitro autoradiography.
    Geisler S; Beindorff N; Cremer M; Hoffmann K; Brenner W; Cumming P; Meyer PT; Langen KJ; Fuchs E; Buchert R
    Synapse; 2015 Oct; 69(10):497-504. PubMed ID: 26126942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations.
    Ko JH; Lee CS; Eidelberg D
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):683-693. PubMed ID: 26980757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
    Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.